The future of CAR T cell therapies is promising, with ongoing research aimed at improving their efficacy and safety. Scientists are exploring ways to enhance the persistence and activity of CAR T cells, reduce side effects, and expand their use to a wider range of cancers. Advances in gene editing technologies like CRISPR may also open new avenues for more precise and effective CAR T cell therapies.
